tradingkey.logo
tradingkey.logo

Roche Receives CE Mark For First IVD Immunoassay Blood Test To Identify Carriers Of ApoE4

ReutersMar 16, 2026 6:04 AM

- ROCHE HOLDING AG ROG.S:

  • RECEIVES CE MARK FOR FIRST IVD IMMUNOASSAY BLOOD TEST TO IDENTIFY CARRIERS OF APOE4, A GENETIC VARIANT PRESENT IN UP TO 60% OF PATIENTS DIAGNOSED WITH ALZHEIMER'S DISEASE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

KeyAI